admin

While the pandemic meant a setback for a number of sectors, digitalization grew apace — increasing the need for software and cloud services. In turn, the demand for cloud computing industry should grow further as more businesses adapt to work-from-home. And thus, software and cloud stocks should be hot options for investors. Overall, shares of
0 Comments
No matter what business it’s been in — smartphones, enterprise software, messaging or embedded automotive software — BlackBerry Ltd. (NYSE:BB) has worked hard to craft an identity around security. However, BB stock was in the headlines on Tuesday when it was announced that a security flaw had been found in its QNX software. Source: Shutterstock
0 Comments
Learn how to use ThinkorSwim to analyze option trades. Thinkorswim analyze tab is similar to other platforms. Of course, there are some small differences, but I’ll show you how to use this analyze tab the right way. #analyzetab #thinkorswim #optiontrades #thinkorswimplatform #analyzetabtutorial Posted at: https://tradersfly.com/blog/option-trades-thinkorswim-analyze-tab-tutorial ? GET MY FREEBIES Freebies ? SUBMIT A VOICE QUESTION
0 Comments
Wall Street is paying close attention to developments in Washington D.C. as President Trump, trade talks, and the Fed continue to make headlines. Nevertheless, indexes are near all-time highs, and Ryan McQueeney has is eyes on two dividend-paying stocks: Caterpillar (CAT) and Sony (SNE). Caterpillar: https://www.zacks.com/stock/quote/CAT?cid=CS-YOUTUBE-FT-VID Sony: https://www.zacks.com/stock/quote/SNE?cid=CS-YOUTUBE-FT-VID
0 Comments
In this article HOOD BJ WOOF TPR KSS M Check out the companies making headlines before the bell: Macy’s (M) – The retailer reported adjusted quarterly earnings of $1.29 per share, well above the 19 cents consensus estimate, with revenue also above forecasts. Macy’s reported a better-than-expected increase in comparable-store sales, raised its annual sales
0 Comments
Investing in the biotechnology sector doesn’t have to be fraught with excessive risk. A case in point would be CRISPR Therapeutics (NASDAQ:CRSP), as CRSP stock offers outstanding value in a market that’s often overpriced. CRISPR’s mission is “Creating transformative gene-based medicines for serious diseases.” The company’s pipeline of therapeutic candidates address serious conditions such as sickle-cell
0 Comments
Does the debt from your college days seem overwhelming? You’re not alone: Student loans in the U.S. total more than $1.6 trillion. That’s second only to the size of the nation’s mortgage debt. Ironically, the burden of student loans is making it harder for college graduates to buy a home. Politicians are debating what to
0 Comments
Cathie Wood Source: CNBC Cathie Wood called out Michael Burry on social media after ‘The Big Short’ investor placed a bet against her flagship ARK Innovation exchange-traded fund. “To his credit, Michael Burry made a great call based on fundamentals and recognized the calamity brewing in the housing/mortgage market. I do not believe that he
0 Comments
I have always wondered about why the memesters decided they liked Clover Health (NASDAQ:CLOV) stock. Source: Shutterstock Maybe it was the short squeeze, which came after Hindenburg Research issued a February report calling the business broken. Maybe it was Chamath Palihapitiya, whom I have likened to Prof. Harold Hill of The Music Man. (Full disclosure:
0 Comments
Gold is one of the best performing assets this year; should investors invest in gold ETFs? (SPY, GLD, IAU). SPDR S&P 500 ETF: https://www.zacks.com/funds/etf/SPY/profile?cid=CS-YOUTUBE-FT-VID SPDR Gold Share: https://www.zacks.com/funds/etf/GLD/profile?cid=CS-YOUTUBE-FT-VID iShares Gold Trust: https://www.zacks.com/funds/etf/IAU/profile?cid=CS-YOUTUBE-FT-VID Follow us on StockTwits: stocktwits.com/ZacksResearch Follow us on Twitter: twitter.com/ZacksResearch Like us on Facebook: www.facebook.com/ZacksInvestmentResearch
0 Comments
In this article PSTH Bill Ackman’s troubled SPAC was hit with a lawsuit Tuesday alleging the blank-check company promised “staggering compensation” to directors and asking that the entity’s special status be revoked. The plaintiffs — former Securities and Exchange Commission commissioner Robert Jackson and Yale law professor John Morley — claim that Pershing Square Tontine
0 Comments